1. Home
  2. ELDN vs ARBE Comparison

ELDN vs ARBE Comparison

Compare ELDN & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • ARBE
  • Stock Information
  • Founded
  • ELDN 2004
  • ARBE 2015
  • Country
  • ELDN United States
  • ARBE Israel
  • Employees
  • ELDN N/A
  • ARBE N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • ARBE EDP Services
  • Sector
  • ELDN Health Care
  • ARBE Technology
  • Exchange
  • ELDN Nasdaq
  • ARBE Nasdaq
  • Market Cap
  • ELDN 164.1M
  • ARBE 182.6M
  • IPO Year
  • ELDN N/A
  • ARBE N/A
  • Fundamental
  • Price
  • ELDN $3.50
  • ARBE $2.17
  • Analyst Decision
  • ELDN Strong Buy
  • ARBE Buy
  • Analyst Count
  • ELDN 2
  • ARBE 2
  • Target Price
  • ELDN $12.50
  • ARBE $1.75
  • AVG Volume (30 Days)
  • ELDN 1.4M
  • ARBE 8.0M
  • Earning Date
  • ELDN 11-11-2025
  • ARBE 11-26-2025
  • Dividend Yield
  • ELDN N/A
  • ARBE N/A
  • EPS Growth
  • ELDN N/A
  • ARBE N/A
  • EPS
  • ELDN 0.21
  • ARBE N/A
  • Revenue
  • ELDN N/A
  • ARBE $536,000.00
  • Revenue This Year
  • ELDN N/A
  • ARBE $301.82
  • Revenue Next Year
  • ELDN N/A
  • ARBE $250.52
  • P/E Ratio
  • ELDN $16.22
  • ARBE N/A
  • Revenue Growth
  • ELDN N/A
  • ARBE N/A
  • 52 Week Low
  • ELDN $2.32
  • ARBE $0.85
  • 52 Week High
  • ELDN $5.54
  • ARBE $5.09
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 70.99
  • ARBE 54.77
  • Support Level
  • ELDN $2.58
  • ARBE $2.17
  • Resistance Level
  • ELDN $2.71
  • ARBE $2.73
  • Average True Range (ATR)
  • ELDN 0.24
  • ARBE 0.28
  • MACD
  • ELDN 0.07
  • ARBE -0.02
  • Stochastic Oscillator
  • ELDN 72.69
  • ARBE 45.87

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

Share on Social Networks: